CClinicalTrials.gg
CompletedNCT03293628Updated Sep 28, 2017

Comparing Two Techniques of Haemostasis After Cervical Conization

A Phase 2 interventional study of Vaginal Packing in Cervical Intraepithelial Neoplasia and Cervix Neoplasm, sponsored by Barretos Cancer Hospital. Completed at 1 site in Brazil. Open to female participants aged 19 Years to 68 Years. Per ClinicalTrials.gov, last updated 2017-09-28.

Sponsored by Barretos Cancer Hospital · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
19 Years to 68 Years
Sex
Female
01

Study summary

The LEEP conization is commonly used for cervical pathologies treatment. The techniques for hemostasis usually used are: cautery, Monsel's solution and vaginal pack. Actually, there is no consensus about the best technique and there is not much information that validates the use of some of that. To compare the use or not of vaginal pack as methods of hemostasis after LEEP conization for management of cervical lesions.

Read the detailed description

A randomized clinical trial was conducted at Gynecology Oncology Department/Barretos Cancer Hospital for patients with indication of LEEP conization. After local IRB approval, patients were allocated in two arms (50 patients each): without vaginal pack (group 1 - GP1) and with vaginal pack (group 2 - GP2). The Monsel's solution was used in all patients. Intraoperative and postoperative outcomes will be evaluated: operative time, intraoperative and postoperative bleeding, hormonal status, age, parity and cone specimens' characteristics as well as short-term outcome were recorded and compared using Chi-square test, Fisher exact test and t-test where appropriate.

02

Conditions studied

  • Cervical Intraepithelial Neoplasia
  • Cervix Neoplasm

Keywords

  • cervical intraepithelial neoplasia
  • haemostasis
  • vaginal pack
  • Loop electrical excision procedure
  • randomized clinical trials
  • uterine cervical neoplasm
03

Who can participate

Ages eligible
19 Years to 68 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Indication of cervical conization.

Exclusion criteria

Exclusion Criteria:

  • We excluded patients who were not treated by our department physicians or if the patient did not return for follow-up.
04

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Conization With Vaginal Packing

    Experimental Arm. Haemostasis at the end of the procedure using vaginal packing and Monsel's solution.

    Procedure: Vaginal Packing

  • Active comparator
    Conization Without Vaginal Packing

    Haemostasis at the end of the procedure using only Monsel's solution.

    Procedure: Vaginal Packing

Interventions

  • ProcedureVaginal Packing

    This study will evaluate the role of vaginal packing after cervical conization as haemostasis technique

05

What researchers measure

Primary outcomes

  1. Vaginal bleeding until 30 days after surgery

    Bleeding was assessed by the need for reintervention.

    Time frame: Until 30 days after surgery

06

Study locations

1 site
  • Hospital do Câncer de Barretos
    Barretos, SP 14784-400, Brazil
07

Registry details

Key details

Study ID
NCT03293628
Lead sponsor
Barretos Cancer Hospital
Responsible party
Ricardo dos Reis (Medical Doctor, Barretos Cancer Hospital) — Principal investigator
First posted
Sep 26, 2017
Start date
Oct 1, 2014
Primary completion
Jun 30, 2015
Completion
Jan 30, 2016
Last update
Sep 28, 2017

Study contacts

Ricardo D Reis, MD
principal investigator · Hospital do Câncer de Barretos

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion